Vir Biotechnology Appoints Suzanne Topalian to Its Board
Vir Biotechnology announced Suzanne Topalian’s appointment to its board of directors.
Related stories
Prysmian Shares Extend Gains, Up 6.4%
M impact | EQUITY | Oct 29, 2026, 01:36 PM UTC
Axalta Q3 Adjusted Earnings Fall as Revenue Rises; Cuts 2026 EPS Outlook
Axalta reported lower adjusted earnings and higher revenue for Q3, and lowered its 2026 adjusted EPS outlook. Shares dropped.
M impact | EQUITY | Oct 29, 2026, 01:36 PM UTC
California Water Service Group Reports Quarterly Results
California Water Service Group reported results for the quarter ended September 30; the alert provides no financial figures.
M impact | EQUITY | Oct 29, 2026, 01:36 PM UTC
ServiceNow shares fall 22% after Q3 profit miss
Shares hit their lowest level since August.
M impact | EQUITY | Oct 29, 2026, 01:35 PM UTC
eBay Shares Rise 1.9% After Q3 Results Beat
M impact | EQUITY | Oct 29, 2026, 01:35 PM UTC
FHLB Cincinnati Announces Third-Quarter 2026 Results
M impact | EQUITY | Oct 29, 2026, 01:35 PM UTC